Detalhe da pesquisa
1.
Antihypertensives and Statin Therapy for Primary Stroke Prevention: A Secondary Analysis of the HOPE-3 Trial.
Stroke
; 52(8): 2494-2501, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985364
2.
Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
N Engl J Med
; 374(21): 2009-20, 2016 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27041480
3.
Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
N Engl J Med
; 374(21): 2032-43, 2016 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27039945
4.
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease.
N Engl J Med
; 374(21): 2021-31, 2016 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27040132
5.
Pulmonary hypertension due to left heart disease.
Eur Respir J
; 53(1)2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545974
6.
May Measurement Month 2017 in Russia: hypertension treatment and control-Europe.
Eur Heart J Suppl
; 21(Suppl D): D101-D103, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31043892
7.
Initial Riociguat Monotherapy and Transition from Sildenafil to Riociguat in Patients with Idiopathic Pulmonary Arterial Hypertension: Influence on Right Heart Remodeling and Right Ventricular-Pulmonary Arterial Coupling.
Lung
; 196(6): 745-753, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30182153
8.
Metabolically healthy obese and metabolically unhealthy non-obese phenotypes in a Russian population.
Eur J Epidemiol
; 32(3): 251-254, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28039558
9.
An international multicenter observational non-interventional prospective study of the efficacy of azilsartan medoxomil in overweight or obese patients with arterial hypertension (CONSTANT).
Curr Med Res Opin
; 37(2): 185-193, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33119420
10.
Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
Biomed Res Int
; 2020: 6836973, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32626754
11.
Overweight and Obesity in the Russian Population: Prevalence in Adults and Association with Socioeconomic Parameters and Cardiovascular Risk Factors.
Obes Facts
; 12(1): 103-114, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30844809
12.
Multiple rare and common variants in APOB gene locus associated with oxidatively modified low-density lipoprotein levels.
PLoS One
; 14(5): e0217620, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31150472
13.
The efficacy and safety of valsartan and combination of valsartan and hydrochlorothiazide in the treatment of patients with mild to moderate arterial hypertension - the VICTORY trial.
Kardiol Pol
; 75(1): 55-64, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27714718
14.
Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
J Hypertens
; 34(1): 139-48, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26630216
15.
Novel Approaches in Primary Cardiovascular Disease Prevention: The HOPE-3 Trial Rationale, Design, and Participants' Baseline Characteristics.
Can J Cardiol
; 32(3): 311-8, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26481083
16.
Randomized evaluation of a novel, fixed-dose combination of perindopril 3.5âmg/amlodipine 2.5âmg as a first-step treatment in hypertension.
J Hypertens
; 33(3): 653-61; discussion 662, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25479022
17.
Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
J Hypertens
; 33(2): 401-11, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25380149
18.
Effects on office and home blood pressure of the lercanidipine-enalapril combination in patients with Stage 2 hypertension: a European randomized, controlled clinical trial.
J Hypertens
; 32(8): 1700-7; discussion 1707, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24906174
19.
Improved Hypertension Control with the Imidazoline Agonist Moxonidine in a Multinational Metabolic Syndrome Population: Principal Results of the MERSY Study.
Int J Hypertens
; 2013: 541689, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23533713
20.
Blood pressure and other determinants of new-onset atrial fibrillation in patients at high cardiovascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease studies.
J Hypertens
; 30(5): 1004-14, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22495138